Vasarya

Vasarya Therapeutics was founded to develop more efficacious, safer drugs for tissue remodeling disorders by leveraging unique opportunities in mechanobiology. Our novel program targets proteins that are only functional in mechanically active tissue, like fibrosis. Our approach leverages exquisite specificity to deliver highly potent drugs with minimal systemic safety concerns, enabling regeneration of healthy tissue.